Clinical Trials Directory

Trials / Conditions / Pleomorphic Rhabdomyosarcoma

Pleomorphic Rhabdomyosarcoma

8 registered clinical trials studyying Pleomorphic Rhabdomyosarcoma — 3 currently recruiting.

StatusTrialSponsorPhase
RecruitingDose-escalated, Hypofractionated, Definitive Proton Radiotherapy for Patients With Inoperable Soft Tissue Sarc
NCT07173972
Oslo University HospitalPhase 2
RecruitingHypofractionated, 3-week, Preoperative Proton or X-ray Radiotherapy for Patients With Localized Soft Tissue Sa
NCT07169344
Oslo University HospitalPhase 2
RecruitingMASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma
NCT06277154
HRYZ Biotech Co.Phase 2
Active Not RecruitingNivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue Sarcoma
NCT04420975
Jonsson Comprehensive Cancer CenterPhase 1
UnknownHypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue Sarcomas
NCT03989596
Maria Sklodowska-Curie National Research Institute of OncologyPhase 2
CompletedRibociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot B
NCT03009201
OHSU Knight Cancer InstitutePhase 1
UnknownHypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Ex
NCT03651375
Maria Sklodowska-Curie National Research Institute of OncologyPhase 2
CompletedSorafenib Tosylate, Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With High-Ri
NCT02050919
OHSU Knight Cancer InstitutePhase 2